Ensign Peak Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-72,610
| Closed | -$1.92M | – | 2130 |
|
|
2022
Q3 | $1.92M | Buy |
72,610
+4,499
| +7% | +$119K | ﹤0.01% | 797 |
|
|
2022
Q2 | $1.68M | Buy |
68,111
+46,441
| +214% | +$1.15M | ﹤0.01% | 873 |
|
|
2022
Q1 | $719K | Hold |
21,670
| – | – | ﹤0.01% | 1386 |
|
|
2021
Q4 | $709K | Sell |
21,670
-9,430
| -30% | -$309K | ﹤0.01% | 1454 |
|
|
2021
Q3 | $1.3M | Hold |
31,100
| – | – | ﹤0.01% | 1323 |
|
|
2021
Q2 | $1.21M | Hold |
31,100
| – | – | ﹤0.01% | 1366 |
|
|
2021
Q1 | $1.06M | Hold |
31,100
| – | – | ﹤0.01% | 1406 |
|
|
2020
Q4 | $1.41M | Hold |
31,100
| – | – | ﹤0.01% | 1245 |
|
|
2020
Q3 | $856K | Hold |
31,100
| – | – | ﹤0.01% | 1370 |
|
|
2020
Q2 | $1.15M | Hold |
31,100
| – | – | ﹤0.01% | 1230 |
|
|
2020
Q1 | $1.01M | Buy |
31,100
+4,400
| +16% | +$142K | ﹤0.01% | 1166 |
|
|
2019
Q4 | $1.09M | Buy |
+26,700
| New | +$1.09M | ﹤0.01% | 1300 |
|